Literature DB >> 12199803

Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people.

Yves Deugnier1, Anne-Marie Jouanolle, Jacques Chaperon, Romain Moirand, Catherine Pithois, Jean-François Meyer, Michel Pouchard, Bernard Lafraise, Alain Brigand, Céline Caserio-Schoenemann, Jean Mosser, Paul Adams, Jean-Yves Le Gall, Véronique David.   

Abstract

Most features of C282Y-linked haemochromatosis support the implementation of population screening of the disorder in Caucasians. However, the penetrance of C282Y homozygosity is poorly documented and the strategy for population screening remains debated. Nine thousand three hundred and ninety-six subjects (3367 men, aged 25-40 years, and 6029 women, aged 35-50 years), attending three Health Appraisal Centres, were genotyped and assessed with respect to clinical and biochemical signs of haemochromatosis. Discriminant, logistic regression and graphic analysis were used to predict homozygosity. Results were validated in 135 homozygotes detected through other family and population studies. Fifty-four subjects (10 men and 44 women) were homozygous for C282Y. All men had abnormal iron status and most had mild clinical symptoms compatible with haemochromatosis. Identification of all homozygous men required a transferrin saturation (TS) threshold of 50% in the study group (90% specificity) and of 40% in the validation group. Homozygous women differed clinically from non-homozygotes for the presence of distal arthralgias only (18%vs 6%, P < 0.03). Thirteen (29%) were iron-deficient (serum ferritin < 13 micro g/l) and undetectable by biochemical tests. Although the population studied was not fully representative of the general population, our data strongly suggests that, in young men, large-scale screening for C282Y homozygosity is justified and can be achieved by using TS prescreening. However, in premenopausal women, large-scale screening remains to be justified with respect to the natural history of haemochromatosis and should be directly genotypic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12199803     DOI: 10.1046/j.1365-2141.2002.03718.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  17 in total

Review 1.  Phenotypic expression of hereditary hemochromatosis: what have we learned from the population studies?

Authors:  Eng K Gan; Oyekoya T Ayonrinde; Debbie Trinder; John K Olynyk
Journal:  Curr Gastroenterol Rep       Date:  2010-02

2.  Serum ferritin and erythrocyte indices in iron overload.

Authors:  Gemino Fiorelli
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

3.  The Southern French registry of genetic hemochromatosis: a tool for determining clinical prevalence of the disorder and genotype penetrance.

Authors:  Patricia Aguilar-Martinez; Michael Bismuth; François Blanc; Pierre Blanc; Severine Cunat; Olivier Dereure; Pierre Dujols; Muriel Giansily-Blaizot; Christian Jorgensen; Amadou Konate; Dominique Larrey; Alain Le Quellec; Thibault Mura; Isabelle Raingeard; Jeanne Ramos; Eric Renard; Florence Rousseau; Jean-François Schved; Marie-Christine Picot
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

4.  Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?

Authors:  E Cadet; D Capron; M Gallet; M-L Omanga-Léké; H Boutignon; C Julier; K J H Robson; J Rochette
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

5.  Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.

Authors:  Patricia Aguilar-Martinez; Bernard Grandchamp; Séverine Cunat; Estelle Cadet; François Blanc; Marlène Nourrit; Kaiss Lassoued; Jean-François Schved; Jacques Rochette
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

Review 6.  Factors influencing disease phenotype and penetrance in HFE haemochromatosis.

Authors:  J Rochette; G Le Gac; K Lassoued; C Férec; K J H Robson
Journal:  Hum Genet       Date:  2010-07-06       Impact factor: 4.132

Review 7.  Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice.

Authors:  Kristina M Utzschneider; Kris V Kowdley
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

8.  The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading.

Authors:  K J Livesey; V L C Wimhurst; K Carter; M Worwood; E Cadet; J Rochette; A G Roberts; J J Pointon; A T Merryweather-Clarke; M L Bassett; A-M Jouanolle; A Mosser; V David; J Poulton; K J H Robson
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

Review 9.  Pathology of hepatic iron overload.

Authors:  Yves Deugnier; Bruno Turlin
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 10.  Recent advances in understanding haemochromatosis: a transition state.

Authors:  K J H Robson; A T Merryweather-Clarke; E Cadet; V Viprakasit; M G Zaahl; J J Pointon; D J Weatherall; J Rochette
Journal:  J Med Genet       Date:  2004-10       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.